A new scholarship advancing addiction recovery in the state of Vermont has been established to support the Vermont Foundation of Recovery (VFOR) by Dominion Diagnostics, a leading national medical laboratory with a two-decade long history in the state and deep roots in its treatment and recovery community.
The North Kingstown Prevention Coalition held a meeting last week to discuss the opioid crisis from both a national and statewide perspective. Along with members of the coalition, North Kingstown Police Officers and Firefighters, Dr. Lisa Marzilli, a pharmacist and expert in pharmacokinetic research, was also on hand to give a presentation and answer questions about the opioid crisis.
Dominion Diagnostics is a well-respected, trusted healthcare company with over two decades of experience and expertise delivering patient-centered drug monitoring solutions, improved treatment outcomes and actionable clinical information to inform care.
Today, Rhode Island-based medical laboratory Dominion Diagnostics joined thousands of other organizations and individuals across the globe to commemorate International Overdose Awareness Day during an event held for its employees. The day itself demands urgent action and is aimed to raise awareness of overdose and reduce the stigma of a drug-related death.
Lawrence Andrade, UC’94, has to stay sharp to outpace street-drug kingpins. As the head of R&D at Dominion Diagnostics, a clinical toxicology lab and a leading maker of drug tests, Andrade’s job is to detect when people have drugs in their system. Not only does he have to stay on top of industry trends and technology, but he also has to keep an eye on the latest drugs to hit the streets. No small task, given the U.S. opioid epidemic, which has led to an explosion of drug abuse and lent new urgency to accurate drug testing.
A pair of nationally recognized leaders for addiction treatment praised Utah for Operation Rio Grande on Thursday — while also urging state officials not to give in to community pushback that inevitably comes with efforts to address homeless issues.
Speaker Greg Hughes will host a conversation on homelessness, substance abuse and mental health with leading experts in the field. Participants will include Dominion Diagnostics Scientific Advisory Board Member David E. Smith, MD and Mary P. Hauser, MA, Vice President of Addiction Services and New Market Development for Dominion Diagnostics.
Today, the Institute for the Advancement of Behavioral Healthcare and Dominion Diagnostics announce they will continue their long-standing partnership over the next two years to support education for addiction treatment professionals facing the substance abuse and addiction crisis.
In 2017, Dominion Diagnostics, LLC celebrated two decades as one of the country's leading drug monitoring companies. Delivering the highest level of commitment to compliance, quality, innovative technology and tools, clinically relevant education and customer support has led them to be a premier choice in laboratory testing for the addiction treatment, behavioral health, and pain management fields.
A new drug called "grey death" has been linked to a handful of lethal overdoses in the South -- but no one knows exactly what's in it or where it's coming from. The drug, a mix of opioids, can kill in very small doses and looks like concrete mixing powder.